Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BioLase Technology, Inc. (BLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Heroic who wrote (245)	12/11/1997 5:35:00 PM
From: Karl Drobnic	Read Replies (1) \| Respond to of 706

John: You are exactly right. Swiss Bank gave a $2.5 mil. credit facility on a company that sold $600,000 of product last qtr. The bank did DD from A to Z and back again. That tells us the orders are coming, but you have to stop and think it through. That's why the shares didn't react. Cosmetic surgery is happening big time in our prosperous economy, mainly for vanity reasons. DermaLase is very precise for skin resurfacing, and it is "cool" versus other methods that are "hot" (traumatic if you're a skin cell). DermaLase could easily sell 15-20 systems/month if the production facility is up to it, and this credit line should ensure that. The credit facility is exciting news, a window on what the order book most likely already shows.